Clinical Trials Browser

Melanoma × cediranib × 1 year × Clear all

NCT01364051 2026-04-13

Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies

Phase 1 Active not recruiting

Melanoma